• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Elite Pharmaceuticals Inc

+ Add to Watchlist


0.183 EUR 0.008 4.57%

As of 15:17:10 ET on 12/23/2014.

Snapshot for Elite Pharmaceuticals Inc (ETF)

Open: 0.177 Day's Range: 0.172 - 0.184 Volume: 0
Previous Close: 0.175 52wk Range: 0.143 - 0.721 1-Yr Rtn: -

Stock Chart for ETF

No chart data available.
  • ETF:GR 0.183
  • 1M
  • 1Y
Interactive ETF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ETF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 109.18
Shares Outstanding (M) 596.61
30 Day Average Volume 1,750
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ETF

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ETF

Elite Pharmaceuticals, Inc. researches, develops, licenses, and manufactures both new and generic oral controlled-release pharmaceutical products. The Company has pain products in clinical trials and has developed products incorporating therapeutic agents such as cardiovasculars, antidiabetic, cough and cold preparations, and anti-infectives.

Nasrat HakimPresident/CEOCarter J WardCFO/Secretary/Treasurer
Ashok G NigalayeChief Scientific Officer
More Company Profile & Key Executives for ETF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • ETF News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil